SBFM SUNSHINE BIOPHARMA INC Capital Structure Changes 8-K Filing 2024 - Reverse Split Sunshine Biopharma, Inc. approved a reverse split of its common stock at a ratio of up to 60-for-1.Get access to all SEC 8-K filings of the SUNSHINE BIOPHARMA INC